McAnear Justin J. 4
4 · 10x Genomics, Inc. · Filed Sep 16, 2022
Insider Transaction Report
Form 4
McAnear Justin J.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-09-14+40,593→ 40,593 totalExercise: $33.67Exp: 2032-09-14→ Class A Common Stock (40,593 underlying) - Award
Class A Common Stock
2022-09-14+20,297→ 78,389 total - Award
Performance-based Restricted Stock Units
2022-09-14+40,593→ 40,593 totalExp: 2026-09-14→ Class A Common Stock (40,593 underlying)
Footnotes (3)
- [F1]Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs vest on each quarterly anniversary measured from August 21, 2022, subject to the Reporting Person continuing as a service provider through each such date.
- [F2]1/48th of the shares subject to the option vest on each monthly anniversary measured from September 14, 2022, subject to the Reporting Person continuing as a service provider through each such date.
- [F3]Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date.